skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Effect of foot-and-mouth disease virus 3C protease B2 β-strand proline mutagenesis on expression and processing of the P1 polypeptide using a plasmid expression vector

Journal Article · · Journal of General Virology
DOI:https://doi.org/10.1099/jgv.0.001204· OSTI ID:1580726
 [1];  [2];  [3];  [4];  [5];  [5]
  1. Oak Ridge Inst. for Science and Education (ORISE), Oak Ridge, TN (United States)
  2. Oak Ridge Inst. for Science and Education (ORISE), Oak Ridge, TN (United States); Coastal Carolina Univ., Conway, SC (United States)
  3. Oak Ridge Inst. for Science and Education (ORISE), Oak Ridge, TN (United States); Bard High School Early College Baltimore, Baltimore, MD (United States)
  4. Leidos, Inc., Greenport, NY (United States)
  5. U.S. Department of Homeland Security Science and Technology Directorate, Greenport, NY (United States)

The production of experimental molecular vaccines against foot-and-mouth disease virus utilizes the viral encoded 3C protease for processing of the P1 polyprotein. Expression of wild type 3C protease is detrimental to host cells. The molecular vaccine constructs containing the 3C protease L127P mutant significantly reduce adverse effects associated with protease expression while retaining the ability to process and assemble virus-like particles. In published 3C protease crystal structures, the L127 residue is contained within the B2 β-strand as part of the A2–B2 β-sheet. To provide insight into the mechanism by which the L127P mutant alters the properties of the 3C protease, we performed scanning proline mutagenesis of residues 123–128 of the B2 β-strand and monitored expression and P1 processing. Simultaneously, we utilized random mutagenesis of the full 3C sequence to identify additional mutations presenting a phenotype similar to the L127P mutation. Six of the tested mutants enhanced expression over wild type, and the I22P, T100P and V124P mutations surpassed the L127P mutation in certain cell lines. These data are interpreted in conjunction with published 3C protease crystal structures to provide insight into the mechanism by which these mutations enhance expression.

Research Organization:
Oak Ridge Inst. for Science and Education (ORISE), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
SC0014664; AC05-06OR23100
OSTI ID:
1580726
Journal Information:
Journal of General Virology, Vol. 100, Issue 3; ISSN 0022-1317
Publisher:
Microbiology SocietyCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 3 works
Citation information provided by
Web of Science

References (23)

Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs journal February 2001
Identification of the Active-Site Residues of the 3C Proteinase of Foot-and-Mouth Disease Virus journal November 1995
Insights into Cleavage Specificity from the Crystal Structure of Foot-and-Mouth Disease Virus 3C Protease Complexed with a Peptide Substrate journal January 2010
Analysis of the aphthovirus 2A/2B polyprotein ‘cleavage’ mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal ‘skip’ journal May 2001
Sequential modification of translation initiation factor eIF4GI by two different foot-and-mouth disease virus proteases within infected baby hamster kidney cells: identification of the 3Cpro cleavage site journal October 2004
Low levels of foot-and-mouth disease virus 3C protease expression are required to achieve optimal capsid protein expression and processing in mammalian cells journal January 2013
Production of Foot-and-mouth Disease Virus Antigen from BHK 21 Clone 13 Cells grown and infected in Deep Suspension Cultures journal March 1965
Crystal structure of the 3C protease from Southern African Territories type 2 foot-and-mouth disease virus journal January 2016
Foot-and-Mouth Disease Virus 3C Protease Cleaves NEMO To Impair Innate Immune Signaling journal June 2012
Protein Coexpression Using FMDV 2A: Effect of “Linker” Residues journal January 2013
The economic impacts of foot and mouth disease – What are they, how big are they and where do they occur? journal November 2013
Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24 journal February 2002
Growth of Foot-and-Mouth Disease Virus in a Fibroblastic Cell Line Derived from Hamster Kidneys journal April 1962
Crystal Structure of Foot-and-Mouth Disease Virus 3C Protease: NEW INSIGHTS INTO CATALYTIC MECHANISM AND CLEAVAGE SPECIFICITY journal January 2005
Evaluation of Gaussia luciferase and foot-and-mouth disease virus 2A translational interrupter chimeras as polycistronic reporters for transgene expression journal June 2017
Cleavage of translation initiation factor 4AI (eIF4AI) but not eIF4AII by foot-and-mouth disease virus 3C protease: identification of the eIF4AI cleavage site journal October 2001
Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo journal April 2009
The nuclear protein Sam68 is cleaved by the FMDV 3C protease redistributing Sam68 to the cytoplasm during FMDV infection of host cells journal March 2012
Analysis of Foot-and-Mouth Disease Virus Type O1 Brugge Neutralization Epitopes Using Monoclonal Antibodies journal October 1986
Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus journal January 2007
Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development journal September 2017
Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity journal February 2013
Development of Replication-Defective Adenovirus Serotype 5 Containing the Capsid and 3C Protease Coding Regions of Foot-and-Mouth Disease Virus as a Vaccine Candidate journal October 1999